Aura 2016 Supplementary data

Table S4.27 Shigella species resistance (faecal isolates), 2014

Antimicrobial	S. sonnei, % resistance (n)	S. flexneri, % resistance (n)
Ampicillin	10.6 (66)	57.1 (21)
Ceftriaxone	3.1 (32)	0.0 (13)
Ciprofloxacin	9.4 (32)	0.0 (12)
Norfloxacin	53.1 (32)	0.0 (7)
Trimethoprim–sulfamethoxazole	75.8 (33)	44.4 (9)

Sources: OrgTRx (Queensland); AGAR (national); SNP (Queensland and northern New South Wales)

Table S4.28 Shigella species resistance, by clinical setting, 2014

Antimicrobial	Public hospitals and health services, % resistance (n)	Community, % resistance (n)
Ampicillin	21.3 (47)	23.7 (38)
Ceftriaxone	2.2 (46)	na
Ciprofloxacin	6.7 (45)	na
Norfloxacin	na	43.6 (39)
Trimethoprim–sulfamethoxazole	na	69.0 (42)

na = not available (either not tested or tested against an inadequate number of isolates)

Sources: OrgTRx, Queensland (public hospitals and health services); SNP (community)

Table S4.29 Staphylococcus aureus resistance, by specimen source, 2014

Antimicrobial	Blood, % resistance (n)	Other, % resistance (n)	Total, % resistance (n)
Penicillin	83.1 (3 758)	88.7 (30 835)	88.1 (34 593)
Oxacillin	17.1 (3 757)	15.8 (67 402)	15.8 (71 159)
Erythromycin	16.9 (3 759)	16.5 (67 431)	16.5 (71 190)
Clindamycin	7.7 (3 764)	13.9 (67 710)	13.6 (71 474)
Tetracycline	5.0 (3 749)	3.4 (62 334)	3.5 (66 083)
Gentamicin	3.3 (3 514)	1.4 (27 898)	1.6 (31 412)
Ciprofloxacin	9.5 (3 514)	4.1 (26 905)	4.7 (30 419)
Trimethoprim–sulfamethoxazole	3.5 (3 759)	2.2 (67 194)	2.3 (70 953)
Fusidic acid	5.4 (3 509)	11.3 (26 821)	10.6 (30 330)
Rifampicin	0.3 (3 458)	0.2 (26 846)	0.2 (30 304)
Nitrofurantoin	0.0 (2 109)	na	0.0 (2 109)
Daptomycin	0.3 (3 664)	0.3 (60 370)	0.3 (64 034)
Linezolid	0.1 (3 657)	0.1 (60 229)	0.1 (63 886)
Vancomycin	0.0 (3 764)	0.0 (26 642)	0.0 (30 406)

na = not available (either not tested or tested against an inadequate number of isolates)

Sources: OrgTRx (Queensland); AGAR (national); SNP (Queensland and northern New South Wales)